Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.4.4.2.1 Pangenotypic direct-acting antiviral combinations |
Others observations: Pangenotypic when used in combination with daclatasvir. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.4.4.2.1 Pangenotypic direct-acting antiviral combinations |
Others observations: Pangenotypic when used in combination with daclatasvir |
| PAHO Strategic Fund Medicine List | 2.6.4.2. Medicines for Hepatitis C | No observations |